Citation: Kosheli Thapa Magar, George Frimpong Boafo, Xiaotong Li, Zhongjian Chen, Wei He. Liposome-based delivery of biological drugs[J]. Chinese Chemical Letters, ;2022, 33(2): 587-596. doi: 10.1016/j.cclet.2021.08.020 shu

Liposome-based delivery of biological drugs

a.
Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
b.
Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China

aajian818@163.com

weihe@cpu.edu.cn

Received Date: 8 May 2021
Revised Date: 30 July 2021
Accepted Date: 5 August 2021
Available Online: 11 August 2021

Figures(5)

Biological drugs are attracting tremendous attention in disease treatment. However, their application is significantly limited by their inherent properties, such as high hydrophilicity, poor membrane-permeability, low stability, and larger size. Liposome-based drug delivery systems are emerging as promising tools to improve their delivery, owing to their ability to reduce toxicity, improve bioavailability, and enhance the therapeutic efficacy of the drug by optimizing delivery to the specific target site. Here, we reviewed the types of liposomes and their applications as carriers for biological drugs to treat various diseases, emphasized the commercial products, and ultimately provided perspectives in this field.
- Liposomes,
- Drug delivery,
- Biological drugs,
- Endocytosis,
- Toxicity
1. [1]
  A.N. Zelikin, C. Ehrhardt, A.M. Healy, Nat. Chem. 8(2016) 997-1007. doi: 10.1038/nchem.2629
2. [2]
  N. Skalko-Basnet, Biologics 8(2014) 107-114.
3. [3]
  Q. Bi, X. Song, A. Hu, et al., Chin. Chem. Lett. 31(2020) 3041-3046. doi: 10.1016/j.cclet.2020.07.030
4. [4]
  T.C. Roberts, R. Langer, M.J.A. Wood, Nat. Rev. Drug Discov. 19(2020) 673-694. doi: 10.1038/s41573-020-0075-7
5. [5]
  Q. Xiao, X. Li, Y. Li, et al., Acta Pharm. Sin. B 11(2020) 941-960.
6. [6]
  W. He, X. Xing, X. Wang, et al., Adv. Funct. Mater. 30(2020) 1910566. doi: 10.1002/adfm.201910566
7. [7]
  M.J. Poznansky, R.L. Juliano, Pharmacol. Rev. 36(1984) 277-336.
8. [8]
  F. Liu, L. Yang, Y. Li, et al., ACS Biomater. Sci. Eng. 6(2020) 1064-1073. doi: 10.1021/acsbiomaterials.9b01722
9. [9]
  Y. Li, R. Jarvis, K. Zhu, et al., Angew. Chem. 132(2020) 15067-15074. doi: 10.1002/ange.202004994
10. [10]
  D. Fu, D. Liu, L. Zhang, L. Sun, Chin. Chem. Lett. 31(2020) 3195-3199. doi: 10.1016/j.cclet.2020.07.011
11. [11]
  R. Cao, W. Sun, Z. Zhang, et al., Chin. Chem. Lett. 31(2020) 3127-3130. doi: 10.1016/j.cclet.2020.06.031
12. [12]
  T. Zhang, Z. Lu, L. Zhang, et al., Chin. Chem. Lett. 31(2020) 3135-3138. doi: 10.1016/j.cclet.2020.07.010
13. [13]
  S. Hua, S.Y. Wu, Front. Pharmacol. 4(2013) 143.
14. [14]
  Y. Li, C. Teng, H.S. Azevedo, L. Yin, W. He, Chin. Chem. Lett. 32(2021) 3071-3075. doi: 10.1016/j.cclet.2021.03.085
15. [15]
  W. Yu, M. Shevtsov, X. Chen, H. Gao, Chin. Chem. Lett. 31(2020) 1366-1374. doi: 10.1016/j.cclet.2020.02.036
16. [16]
  X. Zhou, Y. Hao, L. Yuan, et al., Chin. Chem. Lett. 29(2018) 1713-1724. doi: 10.1016/j.cclet.2018.10.037
17. [17]
  Z. Shi, Q. Li, L. Mei, Chin. Chem. Lett. 31(2020) 1345-1356. doi: 10.1016/j.cclet.2020.03.001
18. [18]
  N.R. Nikam, P.R. Patil, R.R. Vakhariya, C.S. Magdum, Asian J. Pharm. Res. 10(2020) 23-28. doi: 10.5958/2231-5691.2020.00005.2
19. [19]
  M.T. Vitor, P.C. Bergami-Santos, J.A.M. Barbuto, L.G. Torre, Drug Deliv. Formul. 7(2013) 99-110. doi: 10.2174/18722113113079990010
20. [20]
  M.S. Muthu, S.S. Feng, Expert Opin. Drug Deliv. 10(2013) 151-155. doi: 10.1517/17425247.2013.729576
21. [21]
  P.P. Deshpande, S. Biswas, V.P. Torchilin, Nanomedicine (Lond) 8(2013) 1509-1528. doi: 10.2217/nnm.13.118
22. [22]
  T.O. Kabilova, E. V Shmendel, D. V Gladkikh, et al., Eur. J. Pharm. Biopharm. 123(2018) 59-70. doi: 10.1016/j.ejpb.2017.11.010
23. [23]
  S.A. Alanazi, F. Alanazi, N. Haq, et al., Curr. Drug Deliv. 17(2020) 826-844. doi: 10.2174/1567201817666200206104338
24. [24]
  A.D. Bangham, M.M. Standish, J.C. Watkins, J. Mol. Biol. 13(1965) 238-IN27. doi: 10.1016/S0022-2836(65)80093-6
25. [25]
  A.D. Bangham, Liposomes Biol. Syst. (1980) 7-19.
26. [26]
  A. Samad, Y. Sultana, M. Aqil, Curr. Drug Deliv. 4(2007) 297-305. doi: 10.2174/156720107782151269
27. [27]
  C. Zylberberg, S. Matosevic, Drug Deliv 23(2016) 3319-3329. doi: 10.1080/10717544.2016.1177136
28. [28]
  Y.C. Barenholz, J. Control. Release 160(2012) 117-134. doi: 10.1016/j.jconrel.2012.03.020
29. [29]
  B. Layek, B. Gidwani, S. Tiwari, et al., Curr. Pharm. Des. 26(2020) 3218-3233. doi: 10.2174/1381612826666200622133407
30. [30]
  U. Bulbake, S. Doppalapudi, N. Kommineni, W. Khan, Pharmaceutics 9(2017) 12. doi: 10.3390/pharmaceutics9020012
31. [31]
  G. Cuddihy, E.K. Wasan, Y. Di, K.M. Wasan, Pharmaceutics 11(2019) 99. doi: 10.3390/pharmaceutics11030099
32. [32]
  N.R.H. Stone, T. Bicanic, R. Salim, W. Hope, Drugs 76(2016) 485-500. doi: 10.1007/s40265-016-0538-7
33. [33]
  N. Stoicea, J. Fiorda-Diaz, N. Joseph, et al., Drugs 77(2017) 1069-1076. doi: 10.1007/s40265-017-0744-y
34. [34]
  A.A. Voak, A. Harris, J.M. Coteron-Lopez, et al., PLoS Negl. Trop. Dis. 15(2021) e0009013. doi: 10.1371/journal.pntd.0009013
35. [35]
  M. Alam, C.T. Hartrick, Pain Pract 5(2005) 349-353. doi: 10.1111/j.1533-2500.2005.00048.x
36. [36]
  B. Salehi, A.P. Mishra, M. Nigam, et al., Iran. J. Pharm. Res. IJPR 19(2020) 9.
37. [37]
  P. Evelyn, Roopngam, Nanomedicine J. 6(2019) 1-10.
38. [38]
  Z. Lu, X. Wang, T. Zhang, et al., Chin. Chem. Lett. 31(2020) 3139-3142. doi: 10.1016/j.cclet.2020.07.013
39. [39]
  S. Wadhwa, V. Garg, M. Gulati, et al., Pharm. Nanotechnol. (2019) 1-17.
40. [40]
  A. Akbarzadeh, R. Rezaei-Sadabady, S. Davaran, et al., Nanoscale Res. Lett. 8(2013) 1-9. doi: 10.1186/1556-276X-8-1
41. [41]
  A. Catala, Liposomes-Advances Perspect, 2019.
42. [42]
  S.M. Shaheen, F.R. Shakil Ahmed, M.N. Hossen, et al., Pak. J. Biol. Sci. 9(2006) 1181-1191. doi: 10.3923/pjbs.2006.1181.1191
43. [43]
  H. He, Y. Lu, J. Qi, et al., Acta Pharm. Sin. B 9(2019) 36-48. doi: 10.1016/j.apsb.2018.06.005
44. [44]
  N. Van Rooijen, A. Sanders, J. Immunol. Methods 174(1994) 83-93. doi: 10.1016/0022-1759(94)90012-4
45. [45]
  V.S. Chaudhari, U.S. Murty, S. Banerjee, Environ. Chem. Lett. 18(2020) 1-10. doi: 10.1007/s10311-019-00933-6
46. [46]
  V.P. Torchilin, Nat. Rev. Drug Discov. 4(2005) 145-160. doi: 10.1038/nrd1632
47. [47]
  L. Sun, Y. Gao, Y. Wang, et al., Chem. Sci. 9(2018) 5967-5975. doi: 10.1039/C8SC00367J
48. [48]
  R.M. Straubinger, K. Hong, D.S. Friend, D. Papahadjopoulos, Cell 32(1983) 1069-1079. doi: 10.1016/0092-8674(83)90291-X
49. [49]
  Y. Inoh, M. Nagai, K. Matsushita, M. Nakanishi, T. Furuno, Eur. J. Pharm. Sci. 102(2017) 230-236. doi: 10.1016/j.ejps.2017.03.023
50. [50]
  Y.U. Bae, B.K. Kim, J.W. Park, Y.B. Seu, K.O. Doh, Mol. Pharm. 9(2012) 3579-3585. doi: 10.1021/mp300458h
51. [51]
  R. Kolašinac, C. Kleusch, T. Braun, R. Merkel, A. Csiszár, Int. J. Mol. Sci. 19(2018) 346. doi: 10.3390/ijms19020346
52. [52]
  J. Yang, A. Bahreman, G. Daudey, et al., ACS Cent. Sci. 2(2016) 621-630. doi: 10.1021/acscentsci.6b00172
53. [53]
  T. Li, J. He, G. Horvath, et al., Nanomedicine 14(2018) 279-288. doi: 10.1016/j.nano.2017.10.011
54. [54]
  J. He, T. Li, T. Próchnicki, et al., Biochem. Biophys. Rep. 18(2019) 100623.
55. [55]
  X. Tan, F. Jia, P. Wang, K. Zhang, J. Control. Release 323(2020) 240-252. doi: 10.1016/j.jconrel.2020.03.040
56. [56]
  J. Wang, H. Wang, H. Cui, et al., Chin. Chem. Lett. 31(2020) 3143-3148. doi: 10.1016/j.cclet.2020.07.027
57. [57]
  A.J. Mukalel, R.S. Riley, R. Zhang, M.J. Mitchell, Cancer Lett. 458(2019) 102-112. doi: 10.1016/j.canlet.2019.04.040
58. [58]
  S. Beg, W.H. Almalki, F. Khatoon, et al., Drug Discov. Today 26(2021) 1891-1903. doi: 10.1016/j.drudis.2021.02.013
59. [59]
  K. Li, M. Lu, X. Xia, Y. Huang, Chin. Chem. Lett. 32(2020) 1010-1016.
60. [60]
  I. MacLachlan, Antisense Drug Technol. Princ. Strateg. Appl. 2(2007) 237-270.
61. [61]
  A.S.A. Lila, T. Ishida, Biol. Pharm. Bull. 40(2017) 1-10. doi: 10.1248/bpb.b16-00624
62. [62]
  S.C. Semple, A. Akinc, J. Chen, et al., Nat. Biotechnol. 28(2010) 172-176. doi: 10.1038/nbt.1602
63. [63]
  M.T.G. da Cruz, S. Simões, P.P.C. Pires, S. Nir, M.C.P. de Lima, Biochim. Biophys. Acta (BBA)-Biomembranes 1510(2001) 136-151. doi: 10.1016/S0005-2736(00)00342-4
64. [64]
  S. Ramishetti, L. Huang, Ther. Deliv. 3(2012) 1429-1445. doi: 10.4155/tde.12.127
65. [65]
  F. Pastorino, C. Brignole, D. Marimpietri, et al., Clin. Cancer Res. 9(2003) 4595-4605.
66. [66]
  S.E. Wilner, M. Levy, Methods Mol. Biol. 1380(2016) 211-224.
67. [67]
  T.M. Allen, P.R. Cullis, Adv. Drug Deliv. Rev. 65(2013) 36-48. doi: 10.1016/j.addr.2012.09.037
68. [68]
  M. Saad, O.B. Garbuzenko, T. Minko, Nanomedicine (Lond) 3(2008) 761-776. doi: 10.2217/17435889.3.6.761
69. [69]
  Z. Peng, C. Wang, E. Fang, et al., PLoS One 9(2014) e92924. doi: 10.1371/journal.pone.0092924
70. [70]
  I.A. Khalil, M.A. Younis, S. Kimura, H. Harashima, Biol. Pharm. Bull. 43(2020) 584-595. doi: 10.1248/bpb.b19-00743
71. [71]
  T.S. Zimmermann, A.C.H. Lee, A. Akinc, et al., Nature 441(2006) 111-114. doi: 10.1038/nature04688
72. [72]
  G. Basha, T.I. Novobrantseva, N. Rosin, et al., Mol. Ther. 19(2011) 2186-2200. doi: 10.1038/mt.2011.190
73. [73]
  H. Yin, R.L. Kanasty, A.A. Eltoukhy, et al., Nat. Rev. Genet. 15(2014) 541-555. doi: 10.1038/nrg3763
74. [74]
  E.S. Hosseini, M. Nikkhah, S. Hosseinkhani, Int. J. Nanomed. 14(2019) 4353-4366. doi: 10.2147/IJN.S199104
75. [75]
  L. Digiacomo, S. Palchetti, D. Pozzi, et al., Biochem. Biophys. Res. Commun. 503(2018) 508-512. doi: 10.1016/j.bbrc.2018.05.016
76. [76]
  J.A. Kulkarni, J.L. Myhre, S. Chen, et al., Nanomedicine 13(2017) 1377-1387. doi: 10.1016/j.nano.2016.12.014
77. [77]
  P.M. Arnott, H. Joshi, A. Aksimentiev, S. Howorka, Langmuir 34(2018) 15084-15092. doi: 10.1021/acs.langmuir.8b02271
78. [78]
  C. Bellefroid, C. Reusch, A. Lechanteur, et al., Int. J. Pharm. 593(2021) 120122. doi: 10.1016/j.ijpharm.2020.120122
79. [79]
  S. Hosseinpour, C. Xu, L.J. Walsh, J. Photochem. Photobiol. B: Biol. 215(2021) 112108. doi: 10.1016/j.jphotobiol.2020.112108
80. [80]
  D.W. Taylor, Nat. Struct. Mol. Biol. 26(2019) 669-670. doi: 10.1038/s41594-019-0267-1
81. [81]
  D. Basu, Y. Hu, L.A. Huggins, et al., Circ. Res. 122(2018) 560-567. doi: 10.1161/CIRCRESAHA.117.311361
82. [82]
  S. Zhen, X. Li, Cancer Gene Ther. 27(2020) 515-527. doi: 10.1038/s41417-019-0141-7
83. [83]
  M. Li, H. Xie, Y. Liu, et al., J. Control. Release 304(2019) 204-215. doi: 10.1016/j.jconrel.2019.05.019
84. [84]
  Z. Chen, F. Liu, Y. Chen, et al., Adv. Funct. Mater. 27(2017) 1703036. doi: 10.1002/adfm.201703036
85. [85]
  R.S. Schuh, É. Poletto, G. Pasqualim, et al., J. Control. Release 288(2018) 23-33. doi: 10.1016/j.jconrel.2018.08.031
86. [86]
  Y. Liu, L. Mei, C. Xu, et al., Theranostics 6(2016) 177-191. doi: 10.7150/thno.13532
87. [87]
  L. Jubair, A.K. Lam, S. Fallaha, N.A.J. McMillan, PLoS One 16(2021) e0223288. doi: 10.1371/journal.pone.0223288
88. [88]
  L. Wang, W. Zheng, S. Liu, B. Li, X. Jiang, ChemBioChem. 20(2019) 634-643.
89. [89]
  L. Xu, T. Anchordoquy, J. Pharm. Sci. 100(2011) 38-52. doi: 10.1002/jps.22243
90. [90]
  T. Ishida, X. Wang, T. Shimizu, K. Nawata, H. Kiwada, J. Control. Release 122(2007) 349-355. doi: 10.1016/j.jconrel.2007.05.015
91. [91]
  M.A. Dobrovolskaia, S.E. McNeil, Nat. Nanotechnol. 2(2007) 469-478. doi: 10.1038/nnano.2007.223
92. [92]
  X. Liu, F. Wu, Y. Ji, L. Yin, Bioconjug. Chem. 30(2018) 305-324.
93. [93]
  S. Mitragotri, P.A. Burke, R. Langer, Nat. Rev. Drug Discov. 13(2014) 655-672. doi: 10.1038/nrd4363
94. [94]
  M. Yu, J. Wu, J. Shi, O.C. Farokhzad, J. Control. Release 240(2016) 24-37. doi: 10.1016/j.jconrel.2015.10.012
95. [95]
  M.L. Immordino, F. Dosio, L. Cattel, Int. J. Nanomedicine 1(2006) 297-315. doi: 10.2217/17435889.1.3.297
96. [96]
  B.S. Pattni, V. V Chupin, V.P. Torchilin, Chem. Rev. 115(2015) 10938-10966. doi: 10.1021/acs.chemrev.5b00046
97. [97]
  F. Moncalvo, M.I. Martinez Espinoza, F. Cellesi, Front. Bioeng. Biotechnol. 8(2020) 89. doi: 10.3389/fbioe.2020.00089
98. [98]
  M. Niu, Y. Tan, P. Guan, et al., Int. J. Pharm. 460(2014) 119-130. doi: 10.1016/j.ijpharm.2013.11.028
99. [99]
  M. Niu, Y. Lu, L. Hovgaard, et al., Eur. J. Pharm. Biopharm. 81(2012) 265-272. doi: 10.1016/j.ejpb.2012.02.009
100. [100]
  A. Wang, T. Yang, W. Fan, et al., Adv. Healthc. Mater. 8(2019) 1801123. doi: 10.1002/adhm.201801123
101. [101]
  H. Wajant, Cell Death Differ. 22(2015) 1727-1741. doi: 10.1038/cdd.2015.109
102. [102]
  H. Hatamihanza, S.E. Alavi, H. Ebrahimi Shahmabadi, A. Akbarzadeh, Int. J. Pept. Res. Ther. 26(2020) 745-753. doi: 10.1007/s10989-019-09882-8
103. [103]
  R.J. Laborde, O. Sanchez-Ferras, M.C. Luzardo, et al., J. Immunol. 198(2017) 2772-2784. doi: 10.4049/jimmunol.1600310
104. [104]
  Y. Cruz-Leal, D. Grubaugh, C. V Nogueira, et al., Front. Immunol. 9(2018) 2473. doi: 10.3389/fimmu.2018.02473
105. [105]
  Y. Barenholz, Curr. Opin. Colloid Interface Sci. 6(2001) 66-77. doi: 10.1016/S1359-0294(00)00090-X
106. [106]
  N.J. Alves, K.B. Turner, I.L. Medintz, S.A. Walper, Ther. Deliv. 6(2015) 873-887. doi: 10.4155/tde.15.40
107. [107]
  E.G. Gregoriadis, D. Neerunjun, Biochem. Biophys. Res. Commun. 65(1975) 537-544. doi: 10.1016/S0006-291X(75)80180-X
108. [108]
  L.D. Leserman, P. Machy, J. Barbet, Nature 293(1981) 226-228. doi: 10.1038/293226a0
109. [109]
  C.O. Weill, S. Biri, P. Erbacher, Biotechniques 44(2008) vii-vxi. doi: 10.2144/000112832
110. [110]
  B. Chatin, M. Mével, J. Devallière, et al., Mol. Ther. Acids 4(2015) e244. doi: 10.1038/mtna.2015.17
111. [111]
  C. Guo, Y. Chen, W. Gao, et al., Theranostics 7(2017) 775-788. doi: 10.7150/thno.17237
112. [112]
  H. Deng, K. Song, X. Zhao, et al., ACS Appl. Mater. Interfaces 9(2017) 9315-9326. doi: 10.1021/acsami.6b14683
113. [113]
  F. Hajiahmadi, M.Y. Alikhani, H. Shariatifar, M.R. Arabestani, D. Ahmadvand, Int. J. Nanomedicine 14(2019) 5943-5955. doi: 10.2147/IJN.S214521
114. [114]
  S. Portilla, L. Fernández, D. Gutiérrez, A. Rodríguez, P. García, Antibiotics 9(2020) 242. doi: 10.3390/antibiotics9050242
115. [115]
  Y. Cao, M. Zheng, W. Cai, Z. Wang, Chin. Chem. Lett. 31(2020) 463-467. doi: 10.1016/j.cclet.2019.06.024
116. [116]
  R.A. Schwendener, Ther. Adv. Vaccines 2(2014) 159-182. doi: 10.1177/2051013614541440
117. [117]
  A. Vartak, S.J. Sucheck, Vaccines 4(2016) 12. doi: 10.3390/vaccines4020012
118. [118]
  A.C. Allison, G. Gregoriadis, Nature 252(1974) 252.
119. [119]
  H. Xing, K. Hwang, Y. Lu, Theranostics 6(2016) 1336-1352. doi: 10.7150/thno.15464
120. [120]
  L.O. De Serrano, D.J. Burkhart, J. Nanobiotechnology 15(2017) 83. doi: 10.1186/s12951-017-0319-9
121. [121]
  D.S. Watson, A.N. Endsley, L. Huang, Vaccine 30(2012) 2256-2272. doi: 10.1016/j.vaccine.2012.01.070
122. [122]
  I. Jafari, V. Heravi Shargh, M. Shahryari, et al., Immunobiology 223(2018) 493-500. doi: 10.1016/j.imbio.2017.12.003
123. [123]
  E.M. Kim, H.J. Jeong, Chonnam Med. J. 57(2021) 27-35. doi: 10.4068/cmj.2021.57.1.27
124. [124]
  M. Kheirollahpour, M. Mehrabi, N.M. Dounighi, M. Mohammadi, A. Masoudi, Pharm. Nanotechnol. 8(2020) 6-21. doi: 10.2174/2211738507666191024162042
125. [125]
  E.S. Lee, C.S.C. Walker, J.E. Moskowitz, V.A. Johnson, L. V Kendall, Comp. Med. 67(2017) 498-503.
126. [126]
  G. Anderluzzi, S.T. Schmidt, R. Cunliffe, et al., J. Control. Release 330(2021) 933-944. doi: 10.1016/j.jconrel.2020.10.066
127. [127]
  M. Khongkow, T.Y. Liu, S. Bartlett, et al., Precis. Nanomedicine 1(2018) 186-196.
128. [128]
  K.Y. Chyu, P.C. Dimayuga, P.K. Shah, Ther. Adv. Vaccines 5(2017) 39-47. doi: 10.1177/2051013617693753
129. [129]
  H. Hosseini, Y. Li, P. Kanellakis, et al., Cardiovasc. Res. 106(2015) 443-452. doi: 10.1093/cvr/cvv037
130. [130]
  A.A. Momtazi-Borojeni, M.R. Jaafari, A. Badiee, A. Sahebkar, Atherosclerosis 283(2019) 69-78. doi: 10.1016/j.atherosclerosis.2019.02.001
131. [131]
  A. Garu, G. Moku, S.K. Gulla, A. Chaudhuri, Mol. Ther. 24(2016) 385-397. doi: 10.1038/mt.2015.215
132. [132]
  A. Das, M. Asad, A. Sabur, N. Didwania, N. Ali, ACS Appl. Bio Mater. 1(2018) 999-1018. doi: 10.1021/acsabm.8b00184
133. [133]
  M. Lim, A.Z.M. Badruddoza, J. Firdous, et al., Pharmaceutics 12(2020) 30. doi: 10.3390/pharmaceutics12010030
134. [134]
  A. Mehravaran, H. Mirahmadi, J. Akhtari, Nanomedicine J 7(2020) 29-39.
135. [135]
  N. Filipczak, J. Pan, S.S.K. Yalamarty, V.P. Torchilin, Adv. Drug Deliv. Rev. 156(2020) 4-22. doi: 10.1016/j.addr.2020.06.022
136. [136]
  M. Hasan, A. Khatun, T. Fukuta, K. Kogure, Adv. Drug Deliv. Rev. 154-155(2020) 227-235.
137. [137]
  N.B. Charbe, N.D. Amnerkar, B. Ramesh, et al., Acta Pharm. Sin. B 10(2020) 2075-2109. doi: 10.1016/j.apsb.2020.10.005
138. [138]
  T. Ishida, K. Atobe, X. Wang, H. Kiwada, J. Control. Release 115(2006) 251-258. doi: 10.1016/j.jconrel.2006.08.017
1. [1]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
2. [2]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
3. [3]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
4. [4]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
5. [5]
  Deshuai Zhen , Chunlin Liu , Qiuhui Deng , Shaoqi Zhang , Ningman Yuan , Le Li , Yu Liu . A review of covalent organic frameworks for metal ion fluorescence sensing. Chinese Chemical Letters, 2024, 35(8): 109249-. doi: 10.1016/j.cclet.2023.109249
6. [6]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
7. [7]
  Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254
8. [8]
  Lihang Wang , Mary Li Javier , Chunshan Luo , Tingsheng Lu , Shudan Yao , Bing Qiu , Yun Wang , Yunfeng Lin . Research advances of tetrahedral framework nucleic acid-based systems in biomedicine. Chinese Chemical Letters, 2024, 35(11): 109591-. doi: 10.1016/j.cclet.2024.109591
9. [9]
  Yong-Dan Zhao , Yidan Wang , Rongrong Wang , Lina Chen , Hengtong Zuo , Xi Wang , Jihong Qiang , Geng Wang , Qingxia Li , Canqi Ping , Shuqiu Zhang , Hao Wang . Reversing artemisinin resistance by leveraging thermo-responsive nanoplatform to downregulating GSH. Chinese Chemical Letters, 2024, 35(6): 108929-. doi: 10.1016/j.cclet.2023.108929
10. [10]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
11. [11]
  Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
12. [12]
  Yinglan Yu , Sajid Hussain , Jianping Qi , Lei Luo , Xuemei Zhang . Mechanisms and applications: Cargos transport to basolateral membranes in polarized epithelial cells. Chinese Chemical Letters, 2024, 35(12): 109673-. doi: 10.1016/j.cclet.2024.109673
13. [13]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
14. [14]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
15. [15]
  Yunjie Dang , Yanru Feng , Xiao Chen , Chaoxing He , Shujie Wei , Dingyang Liu , Jinlong Qi , Huaxing Zhang , Shaokun Yang , Zhiyun Niu , Bai Xiang . Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters, 2024, 35(12): 109660-. doi: 10.1016/j.cclet.2024.109660
16. [16]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
17. [17]
  Peide Zhu , Yangjia Liu , Yaoyao Tang , Siqi Zhu , Xinyang Liu , Lei Yin , Quan Liu , Zhiqiang Yu , Quan Xu , Dixian Luo , Juncheng Wang . Bi-doped carbon quantum dots functionalized liposomes with fluorescence visualization imaging for tumor diagnosis and treatment. Chinese Chemical Letters, 2024, 35(4): 108689-. doi: 10.1016/j.cclet.2023.108689
18. [18]
  Yi Cao , Xiaojiao Ge , Yuanyuan Wei , Lulu He , Aiguo Wu , Juan Li . Tumor microenvironment-activatable neuropeptide-drug conjugates enhanced tumor penetration and inhibition via multiple delivery pathways and calcium deposition. Chinese Chemical Letters, 2024, 35(4): 108672-. doi: 10.1016/j.cclet.2023.108672
19. [19]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
20. [20]
  Qian Wang , Yeping Bian , Gagan Dhawan , Wei Zhang , Alexander E. Sorochinsky , Ata Makarem , Vadim A. Soloshonok , Jianlin Han . FDA approved fluorine-containing drugs in 2023. Chinese Chemical Letters, 2024, 35(11): 109780-. doi: 10.1016/j.cclet.2024.109780

Get Citation

PDF

XML

Metrics

PDF Downloads(30)
Abstract views(1825)
HTML views(181)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142